Friday, March 28, 2025

Integrative functional genomics in postmortem tissues from the ALS/FTD disease spectrum identify new biomarkers and mechanisms for patient stratification

12:00 PM to 1:00 PM

1060 Biological Sciences Building

Held as part of the MCDB Seminar series and featuring Jack Humphrey, Icahn School of Medicine at Mount Sinai.

Jack Humphrey, Ph.D.

Principal Investigator
Icahn School of Medicine at Mount Sinai

Jack obtained his Ph.D. in Clinical Neuroscience from University College London in 2019, after spending time as a visiting researcher at Stanford University and as a computational scientist at Inivata Ltd, a Cambridge, UK-based biotech startup. He joined the lab of Towfique Raj at Mount Sinai as a postdoctoral fellow in 2019, and was promoted to Instructor in 2021. He is a Visiting Scientist at the New York Genome Center.  In his spare time he goes rock climbing and plays the bass. Read his CV.

At the Humphrey Lab, part of Mount Sinai in New York City, we harness advanced computational tools to explore the genetic and molecular underpinnings of neurodegenerative diseases — progressive and often fatal conditions affecting the brain.

Our primary focus is on Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD), two closely related disorders characterized by shared genetic and pathological features. Join us as we delve into the intricate connections between these diseases to pave the way for innovative research and potential treatments.